Funds holding Lin BioScience Inc
ISIN TW0006696008 · Taiwan
- Fund holders
- 3
- Of which ETFs
- 2 1 other fund
- Value held
- 1.5M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS | 53,716 | 715.8K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 46,686 | 622.1K $ | 0.08 % | as of Jun 30, 2026 ↗ |
| Parametric Tax-Managed Emerging Markets Fund Eaton Vance Series Trust II | 8,517 | 113.8K $ | 0.02 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 0.08 % | as of Jun 30, 2026 ↗ |
| Parametric Tax-Managed Emerging Markets Fund Eaton Vance Series Trust II | 0.02 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 3 | 0 | 108,919 | -1.4 % |
| 2026Q2 | 3 | +1 | 110,488 | +1.7 % |
| 2026Q1 | 2 | 0 | 108,611 | +5.1 % |
| 2025Q4 | 2 | 0 | 103,326 | -2.6 % |
| 2025Q3 | 2 | 0 | 106,095 | +2.5 % |
| 2025Q2 | 2 | 0 | 103,536 | +6.1 % |
| 2025Q1 | 2 | 0 | 97,569 | -0.2 % |
| 2024Q4 | 2 | 0 | 97,777 | +0.9 % |
| 2024Q3 | 2 | 0 | 96,859 | -19.4 % |
| 2024Q2 | 2 | 0 | 120,111 | 0.0 % |
| 2024Q1 | 2 | 0 | 120,111 | +0.6 % |
| 2023Q4 | 2 | 119,397 |
Cite this page
Titelia. "Funds holding Lin BioScience Inc". https://titelia.com/en/stocks/lin-bioscience-inc-TW0006696008